Join
Live feed
·
INSIDERFilingvia Quantisnow
Structure Therapeutics Inc. logo

CHIEF TECHNOLOGY OFFICER Ma Yingli was granted 63,810 units of Ordinary Shares, increasing direct ownership by 174% to 100,539 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
GPCR· Structure Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GPCR (Structure Therapeutics Inc.) and more on Quantisnow.